Drug Trial Radar · NCT02718716
Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
Last checked: Nov 20, 2026Latest source record: Jan 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Mar 2, 2016
Primary completion
Feb 4, 2019
Study completion Feb 4, 2019
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Mar 24, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to check if an subcutaneous (sc) infusion of UCB7665 is safe and tolerated in subjects with primary immune thrombocytopenia.
Conditions
- Thrombocytopenia
Interventions
UCB7665Drug
* Intervention Type: Biological/Vaccine * Pharmaceutical Form: Powder for solution for infusion * Concentration: 100 mg/ml - Route of Administration: Subcutaneous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Experiencing at Least One Treatment Emergent Adverse Event (TEAE) During the StudyTime frame: From Visit 2 (Week 1) until End of Study Visit or Early Termination (up to 12 weeks after the first investigational medicinal product (IMP) administration)
Locations
29 sites in 11 countries. Site status is shown where the registry gives one.
Tp0001 1101
Adelaide, Australia
Tp0001 1302
Pleven, Bulgaria
Tp0001 1301
Sofia, Bulgaria
Tp0001 203
Olomouc, Czechia
Tp0001 201
Prague, Czechia
Tp0001 1201
Tbilisi, Georgia
Tp0001 401
Berlin, Germany
Tp0001 403
Düsseldorf, Germany
Tp0001 404
München, Germany
Tp0001 502
Florence, Italy
Tp0001 506
Torino, Italy
Tp0001 503
Udine, Italy
Tp0001 505
Vicenza, Italy
Tp0001 601
Chisinau, Moldova
Tp0001 702
Bialystok, Poland
Tp0001 703
Gdansk, Poland
Tp0001 701
Lodz, Poland
Tp0001 704
Poznan, Poland
Tp0001 705
Warsaw, Poland
Tp0001 802
Brasov, Romania
Tp0001 801
Bucharest, Romania
Tp0001 803
Craiova, Romania
Tp0001 902
Madrid, Spain
Tp0001 903
Madrid, Spain
Tp0001 901
Valencia, Spain
Tp0001 1001
London, United Kingdom
Tp0001 1002
London, United Kingdom
Tp0001 1003
London, United Kingdom
Tp0001 1004
Truro, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.